Regulatory Conditions Cleared for Novo Holdings’ $16.5 Billion Catalent Acquisition
Novo Holdings announced on Saturday that all regulatory conditions for its $16.5 billion acquisition of U.S. contract drug manufacturer Catalent have been fulfilled. The companies anticipate...